II. Pitfalls
- Avoid lumping
- Acute and Chronic Pain are not treated the same way
-
Opioids are not a universal panacea
- Opioids are not significantly effective in Chronic Pain
- Only 20% will have good relief in some studies
- Opioid tolerance may develop within 2 weeks of start
- Opioids may paradoxically increase pain (Opioid-Induced Hyperalgesia)
- Opioid related adverse effects are common
- Nausea, Vomiting and Constipation
- Respiratory depression
- Lower quality of life and higher depression rate are associated with Chronic Opioid use
- Rates of misuse, abuse, diversion and Overdose have increased substantially since the late 1990s
- Opioids are not significantly effective in Chronic Pain
- Constantly reevaluate therapy
- Discontinue or modify ineffective treatments
- Complete control of Chronic Pain is unrealistic
- Attempting complete pain control will lead to over-medication and complications
- Patients own their Chronic Pain condition and we help them treat it
- In some cases, patients may attempt to guilt a provider into the responsibility of eliminating pain
-
Chronic Pain is unlikely to be completely cured or eliminated
- Consider as chronic disease such as diabetes or heart disease
- Do not expect to fine-tune pain or treat daily breakthrough pain
- At the best, expect 30-40% control of Chronic Pain overall with medical management
- It is patient's job to find ways to control the rest of pain
- Providers can help expand their non-medication toolkit
- Patient needs to establish non-medication strategies for treating the day-to-day flairs
- It is patient's job to find ways to control the rest of pain
- Do not prescribe longterm strategies (e.g. Opioids) to non-compliant patients
- Constantly assess for comorbid conditions
- Major Depression
- Anxiety Disorder (associated with Chronic Pain in up to a third of patients)
- Chemical Dependency
- References
- Belgrade (2009) Chronic Pain Management UMN CME Conference, Minneapolis
III. Protocol
- Complete thorough Pain Evaluation that is updated at each visit
- Consider referral to pain management specialists
- Periodic repeat review of treatment plan and outcomes (Mnemonic: 6 As)
- Analgesia: Pain relief
- Affect: Mood?
- Activities: Quality of Life and Activities of Daily Living
- Adjuncts: Nonpharmacologic and non-Opioid medications
- Adverse Effects: Medication side effects
- Aberrant behavior: Increasing tolerance, Drug Dependence, addiction
- Medical records should reflect systematic process of evaluation and treatment
- Document Pain Evaluation, treatment plan, Consultation, Informed Consent and contracts
- Document medication history
- Document high risk behaviors (e.g. drug seeking)
- Follow a written treatment plan
- Include both non-pharmacologic (e.g. lifestyle) and medications
- Establish realistic objectives of successful treatment
- Address future diagnostic testing if needed
- Obtain Informed Consent
- Risks and benefits are discussed
- Pain Contract should be a part of the normal process
- Discuss reasons for cessation of treatment (breaking contract)
- Consider Urine Drug Screening
IV. Management: Emergency Department Protocols
- Flag patients who meet criteria for a formal pain management plan
- Assign patients record for review by a patient care coordinator (e.g. RN, social worker)
- Review and summarize complicated history and prior treatment
- Establish Comprehensive care plan for Narcotic administration and pain management
- Emergency department staff
- Primary care team
- Pain management Consultation
V. Management: General
- Treat specific conditions (each condition has specific guidelines for non-pharmacologic pain management)
- No single pain reduction strategy works in every painful condition
- Low Back Pain
- General Exercise, motor control Exercises, Yoga and Tai Chi
- Cognitive Behavioral Therapy (CBT), Pain Physiology education, Mindfulness, Progressive Muscle Relaxation
- Spinal Manipulation, Acupuncture, dry needling, massage (short-term), low level laser therapy (short-term)
- Interdisciplinary pain rehabilitation
- Neck Pain
- Neck, upper back and Shoulder Exercises and motor control Exercises
- Cognitive Behavioral Therapy (CBT)
- Spinal Manipulation, Acupuncture, trapezius Trigger Point Injection, low level laser therapy (short-term)
- Radicular pain
- Hip Osteoarthritis
- Knee Osteoarthritis
- Fibromyalgia
- General Exercise, aerobic, strength and aquatic Exercise, yoga, Tai Chi
- Cognitive Behavioral Therapy (CBT), Guided Imagery or Hypnosis
- Acupuncture, Myofacial release, low level laser therapy (short-term)
- Interdisciplinary pain rehabilitation
- References
- Set realistic goals (complete elimination of pain is not realistic)
- Decrease physical limitations and improve occupational functioning
- Improve social, psychological and interpersonal functioning
- Improve quality of life by increasing pleasurable activities
- Patient Education regarding Pain Physiology
- Lifestyle changes
- Tobacco Cessation
- Weight loss
- Exercise
- Stretching and Yoga
- Treat Myofascial Pain
- Consider physical rehabilitation methods
- Approach is similar to treatment of Somatization
- Non-Pharmacologic Management is critical
- See Somatization Management
- See Somatoform Disorder Management Pitfalls
VI. Management: Pharmacologic
- Medications augment non-pharmacologic management
- Analgesics
-
Tricyclic Antidepressants
- Nighttime only use (Tertiary amines)
- Daytime and nighttime use (Secondary amines)
-
Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
- Venlafaxine (Effexor)
- Duloxetine (Cymbalta)
- Of the newer Antidepressants (non-tricyclics), only SNRIs appear effective in Chronic Pain
- Anticonvulsants
- Indicated for sharp, lancinating, intermittent pain
- Potential Agents
- Gabapentin (Neurontin)
- Most studied anticonvulsant for neuropathic pain
- Titrate to effective doses (2400 to 3600 mg/day)
- Indications
- Carbamazepine (Tegretol)
- Primary indication: Trigeminal Neuralgia
- Other indications with modest efficacy
- Pregabalin (Lyrica)
- New agent pending FDA approval in 2005
- Indications
- Phenytoin (Dilantin)
- Valproic Acid (Depakote)
- Lamotrigine (Lamictal)
- Topiramate (Topamax)
- Gabapentin (Neurontin)
- Adjunctive agents
- Caffeine 65 to 200 mg
- Hydroxyzine (Atarax, Vistaril)
- Enhances Opioid Analgesic effect
- Reduces Opioid associated Nausea and Vomiting
- Step-wise approach to pain management
- Start with Non-Opioid Analgesics (see above) and adjunctive agents (see above)
- Avoid Opioids if possible
- Avoid Benzodiazepines
- Experimental protocols: Cannabinoids
- CT-3 appears to reduce neuropathic pain
- Karst (2003) JAMA 290:1757-62 [PubMed]
VII. Resources
- Prescription Drug Monitoring Programs (alliance of states sites)
VIII. References
- (2014) Presc Lett 21(12): 67
- Ansari (2000) Harv Rev Psychiatry 7:257 [PubMed]
- Barkin (2000) Am J Ther 7:31 [PubMed]
- Bajwa (1999) Neurology 52:1917 [PubMed]
- Berland (2012) Am fam Physician 86(3): 252-8 [PubMed]
- Dellemijn (1999) Pain 80:453 [PubMed]
- Jackman (2008) Am Fam Physician 78(10): 1155-62 [PubMed]
- Kingery (1997) Pain 73:123 [PubMed]
- Laird (2000) Ann Pharmacother 34:802 [PubMed]
- Lembke (2016) Am Fam Physician 93(12): 982-90 [PubMed]
- Maizels (2005) Am Fam Physician 71(3):483-90 [PubMed]
- McQuay (1995) BMJ 311:1047 [PubMed]
- Sindrup (1999) Pain 83:389 [PubMed]
- (2000) Med Lett Drugs Ther 42(1085):73-8 [PubMed]